Vertex Pharmaceuticals
VRTX
#175
Rank
C$161.33 B
Marketcap
C$629.25
Share price
-0.41%
Change (1 day)
-3.75%
Change (1 year)

Earnings for Vertex Pharmaceuticals (VRTX)

Earnings in 2025 (TTM): C$6.25 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's current earnings are C$11.72 Billion. In 2024 the company made an earning of C$0.38 Billion a decrease over its 2023 earnings that were of C$6.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vertex Pharmaceuticals from 1990 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) C$6.25 B1521.95%
2024 C$0.38 B-93.69%
2023 C$6.11 B3.19%
2022 C$5.92 B53.56%
2021 C$3.85 B-12.06%
2020 C$4.38 B118.45%
2019 C$2.00 B120.64%
2018 C$0.91 B1473.64%
2017 C$57.83 M197.6%
2016 C$19.43 M-102.97%
2015 -C$0.66 Billion-28.46%
2014 -C$0.92 Billion-51.5%
2013 -C$1.89 Billion-30584.68%
2012 C$6.18 M-95.47%
2011 C$0.13 B
2009 -C$0.82 Billion
2007 -C$0.58 Billion83.1%
2006 -C$0.32 Billion59.02%
2005 -C$0.2 Billion3.28%
2004 -C$0.19 Billion-38.16%
2003 -C$0.31 Billion
2000 -C$52.56 Million-20.38%
1999 -C$66.01 Million31.62%
1998 -C$50.15 Million91.05%
1997 -C$26.25 Million-36.24%
1996 -C$41.17 Million12.45%
1995 -C$36.61 Million27.4%
1994 -C$28.74 Million-1833.33%
1993 C$1.65 M-112.12%
1992 -C$13.68 Million175%
1991 -C$4.98 Million-12.2%
1990 -C$5.67 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
C$13.65 B 121.58%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$2.29 B-62.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$31.89 B 417.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$11.09 B 80.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$44.75 B 626.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
-C$0.12 Billion-101.93%๐Ÿ‡บ๐Ÿ‡ธ USA